Anna Maria Barbui

2.3k total citations
61 papers, 1.2k citations indexed

About

Anna Maria Barbui is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, Anna Maria Barbui has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 18 papers in Oncology and 16 papers in Infectious Diseases. Recurrent topics in Anna Maria Barbui's work include Lymphoma Diagnosis and Treatment (12 papers), Antifungal resistance and susceptibility (10 papers) and Viral-associated cancers and disorders (7 papers). Anna Maria Barbui is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Antifungal resistance and susceptibility (10 papers) and Viral-associated cancers and disorders (7 papers). Anna Maria Barbui collaborates with scholars based in Italy, United States and France. Anna Maria Barbui's co-authors include Alessandro Rambaldi, Josée Golay, Martino Introna, Rossana Cavallo, Tiziano Barbui, Michele Falda, Donatella Amico, Andrea Biondi, Alessandro Busca and Gianmaria Borleri and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Anna Maria Barbui

58 papers receiving 1.2k citations

Peers

Countries citing papers authored by Anna Maria Barbui

Since Specialization

Citations

This map shows the geographic impact of Anna Maria Barbui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Maria Barbui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Maria Barbui more than expected).

Fields of papers citing papers by Anna Maria Barbui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Maria Barbui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Maria Barbui. The network helps show where Anna Maria Barbui may publish in the future.

Co-authorship network of co-authors of Anna Maria Barbui

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Maria Barbui. A scholar is included among the top collaborators of Anna Maria Barbui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Maria Barbui. Anna Maria Barbui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Performance Evaluation of BD Phoenix and MicroScan WalkAway plus for Determination of Fosfomycin Susceptibility in Enterobacterales 2023 ·Antibiotics ·Alessandro Bondi, Antonio Curtoni, (unknown), Elisa Zanotto, Matteo Boattini, Gabriele Bianco, Marco Iannaccone, Anna Maria Barbui, Rossana Cavallo, Cristina Costa	2
2	A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold 2022 ·Journal of Fungi ·Tommaso Lupia, Giorgia Montrucchio, (unknown), (unknown), (unknown), (unknown), Nour Shbaklo, (unknown), (unknown), (unknown), (unknown), Anna Maria Barbui, Luca Brazzi, Francesco Giuseppe De Rosa, Silvia Corcione	3
3	The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy) 2022 ·Infection ·(unknown), Alessandro Bondi, Doug Lombardi, Paolo Bottino, Elisa Zanotto, Anna Maria Barbui, Rossana Cavallo	5
4	Comparison of Three Different Commercial Methods for Fosfomycin Susceptibility Testing in Pseudomonas aeruginosa 2022 ·Microbial Drug Resistance ·(unknown), Alessandro Bondi, Gabriele Bianco, Marco Iannaccone, Anna Maria Barbui, Cristina Costa, Rossana Cavallo	3
5	FIRST REPORT OF THE REAL‐LIFE PROSPECTIVE OBSERVATIONAL STUDY “CAR‐T CELL IN DIFFUSE LARGE B‐CELL AND PRIMARY MEDIASTINAL LYMPHOMAS” OF THE ITALIAN SOCIETY OF HEMATOLOGY 2021 ·Hematological Oncology ·Annalisa Chiappella, Anna Guidetti, Anna Dodero, Stéfania Bramanti, Pier Luigi Zinzani, Armando Santoro, Beatrice Casadei, Alice Di Rocco, Matteo Giovanni Carrabba, Patrizia Chiusolo, Massimo Martino, Anna Maria Barbui, Maria Chiara Tisi, Rosalba Miceli, Cristiana Carniti, Paolo Corradini	2
6	Clinical features of respiratory syncytial virus bronchiolitis in an infant: rapid and fatal brain involvement 2021 ·BMC Pediatrics ·Paolo Bottino, (unknown), (unknown), Anna Maria Barbui, Giovanni Botta, Elisa Zanotto, Francesca Sidoti, Cristina Costa, Rossana Cavallo	8
7	Evaluation of BD Phoenix and Microscan WalkAway for determination of fosfomycin susceptibility in Staphylococcus aureus 2020 ·Diagnostic Microbiology and Infectious Disease ·Alessandro Bondi, (unknown), Gabriele Bianco, (unknown), Anna Maria Barbui, Cristina Costa, Rossana Cavallo	4
8	Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety 2018 ·Journal of Clinical Oncology ·Wolfgang Hiddemann, Anna Maria Barbui, Miguel Canales, Paul Cannell, Graham P. Collins, Jan Dürig, Roswitha Forstpointner, Michael Herold, Mark Hertzberg, Magdalena Klánová, John Radford, John F. Seymour, Kensei Tobinai, Judith Trotman, (unknown), Günter Fingerle‐Rowson, (unknown), Tina Nielsen, Robert Marcus	144
9	Louse-borne relapsing fever in a refugee from Mali 2017 ·Infection ·Cecilia Grecchi, (unknown), Agostina Pontarelli, (unknown), Lina Rachele Tomasoni, Maurizio Gulletta, Anna Maria Barbui, Silvio Caligaris, Alberto Matteelli, Francesco Castelli	12
10	Subgingival Microbiota in White Patients With Desquamative Gingivitis: A Cross‐Sectional Study 2017 ·Journal of Periodontology ·Paolo G. Arduino, Federica Romano, (unknown), Roberto Broccoletti, Fulvio Ricceri, Anna Maria Barbui, (unknown), (unknown), (unknown), Marco Cabras, Mario Aimetti	12
11	Time trend analysis (2009-2016) of antimicrobial susceptibility in Neisseria gonorrhoeae isolated in Italy following the introduction of the combined antimicrobial therapy 2017 ·PLoS ONE ·Paola Stefanelli, Maria Fenicia Vescio, Maria Paola Landini, Ivano Dal Conte, Alberto Matteelli, Antonio Cristaudo, (unknown), Marco Cusini, Anna Maria Barbui, Antonella Mencacci, Rosella De Nittis, Valeria Ghisetti, Elena Stroppiana, Anna Carannante, (unknown)	14
12	Rapid Identification of Microorganisms from Positive Blood Culture by MALDI-TOF MS After Short-Term Incubation on Solid Medium 2016 ·Current Microbiology ·Antonio Curtoni, (unknown), (unknown), Anna Maria Barbui, Rossana Cavallo, Cristina Costa	36
13	Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study 2012 ·Leukemia & lymphoma ·Angelo Michele Carella, Cármino Antônio De Souza, Stefano Luminari, Luigi Marcheselli, Annalisa Chiappella, Alice Di Rocco, Marina Cesaretti, Andrea Rossi, Luigi Rigacci, Gianluca Gaïdano, Francesco Merli, Michele Spina, Caterina Stelitano, Stefan Hohaus, Anna Maria Barbui, Benedetta Puccini, Eliana Miranda, (unknown), Massimo Federico	36
14	The reversed halo sign as the initial radiographic sign of pulmonary zygomycosis 2011 ·Infection ·Alessandro Busca, Giorgio Limerutti, Franco Locatelli, Anna Maria Barbui, Francesco Giuseppe De Rosa, Michele Falda	16
15	Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study 2007 ·Haematologica ·Martino Introna, Gianmaria Borleri, Elena Conti, Marina Franceschetti, Anna Maria Barbui, Raewyn Broady, Erica Dander, Giuseppe Gaipa, Giovanna D’Amico, E. Biagi, Matteo Parma, Enrico Maria Pogliani, Orietta Spinelli, D Baronciani, Anna Grassi, Josée Golay, Tiziano Barbui, Andrea Biondi, Alessandro Rambaldi	153
16	Gemtuzumab ozogamicin (Mylotarg) has therapeutic activity against CD33⁺ acute lymphoblastic leukaemias in vitro and in vivo 2005 ·British Journal of Haematology ·Josée Golay, Nicola Di Gaetano, Donatella Amico, (unknown), Anna Maria Barbui, Raffaella Giavazzi, Andrea Biondi, Alessandro Rambaldi, Martino Introna	36
17	Immune Reconstitution and Early Infectious Complications Following Nonmyeloablative Hematopoietic Stem Cell Transplantation 2003 ·Hematology ·Alessandro Busca, (unknown), Sabrina Aliberti, Franco Locatelli, Anna Serra, Patrizia Scaravaglio, Paola Omedè, Giuseppe Rossi, Daniela María Cirillo, Anna Maria Barbui, Valeria Ghisetti, (unknown), Michele Falda	22
18	Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation 2003 ·Transplant Infectious Disease ·Alessandro Busca, Francesco Locatelli, Anna Maria Barbui, Valeria Ghisetti, Daniela María Cirillo, Roberto Serra, Ernesta Audisio, Michele Falda	23
19	Correlation between Cytomegalovirus Infection and Raynaud’s Phenomenon in Lupus nephritis 1999 ·The Nephron journals/Nephron journals ·Piero Stratta, Caterina Canavese, Giovannino Ciccone, (unknown), Marco Quaglia, Valeria Ghisetti, G. Marchiaro, Anna Maria Barbui, Fabrizio Fop, Rossana Cavallo, (unknown)	39
20	Rapid retroviral infection of human haemopoietic cells of different lineages: efficient transfer in fresh T cells 1998 ·British Journal of Haematology ·Martino Introna, Anna Maria Barbui, Josée Golay, (unknown), R Schirò, Sergio Bernasconi, Ferruccio Breviario, Eugenio Erba, Gianmaria Borleri, Tiziano Barbui, Andrea Biondi, Alessandro Rambaldi	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact